Catalyst Pharmaceutical
CPRX
CPRX
335 hedge funds and large institutions have $2.04B invested in Catalyst Pharmaceutical in 2024 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 139 increasing their positions, 92 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 314 → 335 (+21)
1.41% more ownership
Funds ownership: 80.36% → 81.78% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
335
Holding in Top 10
3
Calls
$490K
Puts
$248K
Top Buyers
| 1 | +$28.6M | |
| 2 | +$19.6M | |
| 3 | +$14.7M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$10.4M |
Top Sellers
| 1 | -$66.5M | |
| 2 | -$13M | |
| 3 | -$8.12M | |
| 4 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$8.09M |
| 5 |
Jane Street
New York
|
-$7.83M |